Impairment in Coupled Beta-Adrenergic Receptor and Adenylate Cyclase System during Bleomycin-Induced Lung Fibrosis in Hamsters
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Experimental Lung Research
- Vol. 13 (4) , 401-416
- https://doi.org/10.3109/01902148709069601
Abstract
The purpose of this study was to evaluate the coupled beta-adrenergic receptor (BAR) and adenylate cyclase (AC) system of the lung during the course of the bleomycin-(Bleo) induced pulmonary fibrosis in hamsters. The BAR population, dissociation constants (Kd), AC activity, and its sensitivity to various stimulators were studied at 2, 4, 7, 14, and 21 days after intratracheal administration of either 1 unit of Bleo or an equivalent volume of saline. The BAR population in the lungs of Bleo-treated animals did not differ from control at the early times, but it was significantly reduced to 5.9 × 103 fmol and 3.6 × 103 fmol from the control values of 1.1 × 104 fmol and 1.5 × 104 fmol per lung at 14 and 21 days after treatment, respectively. The Kd values for control hamster lung ranged from 2.5 × 10−11 M to 3.7 × 10−11 M, and for Bleo-treated hamster lung, from 2.7 × 10−11 M to 4.8 × 10−11 M. The Kd at the earliest time, 2 days after treatment, did not differ significantly from the Kd values at the subsequent times in control, while for Bleo-treated hamster lung, the Kd values at 7, 14, and 21 days were significantly higher than the Kd at 2 days after treatment. The Kd values for Bleo-treated hamster lung were also significantly higher than control at 14 and 21 days. The AC activity of the lung in Bleo-treated hamster was significantly reduced to 67%, 40%, 38%, and 50% of their respective controls in response to H2O (basal), GTP (10−4 M), GTP + isoproterenol (10−4 M each), and NaF (10 mM) at 21 days after treatment. The extent of AC stimulation in Bleo-treated hamster lung in response to various stimulators was generally less than that of saline control. Reductions in the BAR population and increased Kd values in Bleo-treated hamster lung were attributed to its fibrogenic ability and not to nutritional deficiency, which may partly be accountable for decreased AC activity of the lung in these animals. However, there were qualitative differences in the lung AC activity between Bleo-treated and nutritionally deprived hamsters, since the enzyme from the latter group was generally more responsive to stimulators than the enzyme from the former group. It was concluded from the findings of this study that an impairment in the coupled BAR and AC system of the lung may be partly responsible for the fibrogenic ability of bleomycin.This publication has 34 references indexed in Scilit:
- Analysis of Bronchoalveolar Lavage Fluid from Bleomycin-Induced Pulmonary Fibrosis in HamstersToxicologic Pathology, 1986
- Effects of intratracheal administration of bleomycin or saline in pair-fed and control-fed hamsters on daily food intake and on plasma levels of glucose, cortisol, and insulin, and lung levels of calmodulin, calcium, and collagenExperimental and Molecular Pathology, 1985
- Effects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation, and collagen content in the lungs of hamstersToxicology and Applied Pharmacology, 1983
- Effects of paraquat on plasma glucose, cortisol, catecholamines, and insulin in the beagleEnvironmental Research, 1983
- Increases in cyclic AMP potentiate competence formation in BALB/c‐3T3 cellsJournal of Cellular Physiology, 1982
- Regulation of Collagen Production by the β-Adrenergic SystemJournal of Clinical Investigation, 1981
- Pulmonary toxicity of bleomycin analogsToxicology and Applied Pharmacology, 1980
- Biochemical and structural alterations of hamster lungs in response to intratracheal administration of bleomycinExperimental and Molecular Pathology, 1980
- Bleomycin-Induced Diffuse Interstitial Pulmonary Fibrosis in BaboonsJournal of Clinical Investigation, 1978
- A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissuesLife Sciences, 1976